Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Renal Cell 35Kidney Neoplasms 8Neoplasms 6Neoplasm Metastasis 6Carcinoma, Non-Small-Cell Lung 6Melanoma 5Carcinoma, Hepatocellular 5Colorectal Neoplasms 4Recurrence 3Lung Neoplasms 3Glioblastoma 3Carcinoma 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Sarcoma 2Pheochromocytoma 2Paraganglioma 2Liver Neoplasms 2Endometrial Neoplasms 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Adenoid Cystic 2cT2a N0NxM0 Renal Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Solitary Fibrous Tumors 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Relapsed Pediatric Solid Tumor 1Radiation Therapy 1

Interventions

lanreotide 3cabozantinib 3Nivolumab 3Everolimus 3pasireotide 2lutetium Lu 177 dotatate 2ganitumab 2Sunitinib 2Octreotide 2Erlotinib Hydrochloride 2Bevacizumab 2zimberelimab 1telotristat ethyl 1recombinant interferon alpha 2b-like protein 1pertuzumab 1pembrolizumab 1nintedanib 1ibrutinib 1fosbretabulin 1epothilone B 1conatumumab 1cixutumumab 1carfilzomib 1azaspirane 1aflibercept 1Temozolomide 1Somatostatin 1Random Allocation 1Ramucirumab 1Panitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoid Tumor × Axitinib × Clear all
NCT01435122 2018-10-02

A Study of Axitinib in Advanced Carcinoid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
30 enrolled 10 charts
Endocrine

Carcinoid Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡